Cases 51 - 60 of 124
ViiV Healthcare Company et al v. Lupin Limited et al
as 1:2020cv00293
Plaintiff:
ViiV Healthcare UK (No. 3) Limited, Shionogi & Co., Ltd. and ViiV Healthcare Company
Defendant:
Lupin Limited and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Gilead Sciences, Inc. v. Apotex, Inc. et al
as 1:2020cv00189
Defendant:
Macleods Pharmaceuticals Ltd., Cipla Limited, Apotex, Inc. and others
Plaintiff:
Gilead Sciences, Inc.
Cause Of Action: 35 U.S.C. § 1
CyDex Pharmaceuticals, Inc. v. Lupin Limited et al
as 1:2019cv02043
Defendant:
Lupin Pharmaceuticals, Inc. and Lupin Limited
Plaintiff:
CyDex Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Otsuka Pharmaceutical Co., Ltd. et al v. Lupin Limited et al
as 1:2019cv01988
Defendant:
Lupin Pharmaceuticals, Inc. and Lupin Limited
Plaintiff:
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Alkem Laboratories Ltd. et al
as 1:2019cv01979
Defendant:
Teva Pharmaceuticals USA, Inc., Aurobindo Pharma USA Inc., Lupin Inc. and others
Plaintiff:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
as 1:2019md02902
Counter Defendant:
Merck Sharp & Dohme Corp.
Not Classified By Court:
Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Limited and others
Counter Claimant:
Macleods Pharmaceuticals Limited
In Re:
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
Defendant:
Accord Healthcare, Inc., Teva Pharmaceutical Industries Ltd., Inventia Healthcare Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Eisai Co., Ltd. et al v. Lupin Limited et al
as 1:2019cv01336
Plaintiff:
Novartis Pharma AG, Eisai Inc. and Eisai Co., Ltd.
Defendant:
Lupin Pharmaceuticals, Inc. and Lupin Limited
Cause Of Action: 35 U.S.C. § 271
In re: Kerydin (Tavaborole) Topical Solution 5% Patent Litigation
as 1:2019md02884
Counter Claimant:
Glasshouse Pharmaceuticals Limited Canada
Not Classified By Court:
Taro Pharmaceuticals U.S.A., Inc., Aurobindo Pharma Limited, Zydus Pharmaceuticals (USA) Inc. and others
In Re:
Kerydin (Tavaborole) Topical Solution 5% Patent Litigation
Counter Defendant:
Anacor Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
MITSUBISHI TANABE PHARMA CORPORATION et al v. LUPIN LIMITED et al
as 3:2019cv07165
Plaintiff:
JANSSEN RESEARCH AND DEVELOPMENT, LLC, JANSSEN PHARMACEUTICA NV, MITSUBISHI TANABE PHARMA CORPORATION and others
Defendant:
LUPIN LIMITED and LUPIN PHARMACEUTICALS, INC.
Cause Of Action: 28 U.S.C. § 1338
Merck Sharp & Dohme Corp. v. Lupin Limited et al
as 1:2019cv00347
Defendant:
Lupin Pharmaceuticals, Inc. and Lupin Limited
Plaintiff:
Merck Sharp & Dohme Corp.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
